Relias Media - Continuing Medical Education Publishing

The trusted source for

healthcare information and

CONTINUING EDUCATION.

  • Sign In
  • Sign Out
  • MyAHC
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Live Webinars
      • On-Demand Webinars
      • Libraries
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Live Webinars
      • On-Demand Webinars
      • Libraries
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Live Webinars
      • On-Demand Webinars
    • All Access
      • Learn More
      • My Subscription
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    Home » Is Bileaflet Mitral Valve Prolapse Associated with Sudden Death?

    Is Bileaflet Mitral Valve Prolapse Associated with Sudden Death?

    September 1, 2013
    No Comments
    Reprints
    Facebook Twitter Linkedin Share Share

    Related Articles

    Mitral Valve Prolapse in Marfan Syndrome

    Outcome of Mitral Valve Repair for Severe Mitral Regurgitation

    Keywords

    heart disease

    Cardiology

    Is Bileaflet Mitral Valve Prolapse Associated with Sudden Death?

    Abstract & Commentary

    Edward P. Gerstenfeld, MD Professor of Medicine, Chief, Cardiac Electrophysiology, University of California, San Francisco

    Dr. Gerstenfeld does research for Biosense Webster, Medtronic, and Rhythmia Medical.

    Source: Sriram CS, et al. Malignant bileaflet mitral valve prolapse syndrome in patients with otherwise idiopathic out of hospital cardiac arrest. J Am Coll Cardiol 2013;62:222-230.

    Mitral valve prolapse (MVP), characterized by displacement of the mitral valve into the left atrium during systole, was first described by Barlow in 1966. MVP "syndrome" refers to the association of MVP with palpitations and atypical chest pain in young patients. There has been some association of MVP with sudden cardiac arrest (SCA), primarily from autopsy studies finding pathologic signs of MVP in up to 10% of SCA survivors. However, given the high prevalence of MVP in the general population, a true association with SCA risk has been controversial.

    The laboratory at the Mayo clinic analyzed records from 1200 consecutive patients seen in their genetic Heart Rhythm clinic between July 2000 and December 2009. In this database, all patients had received transthoracic echocardiography and standard electrocardiograms, and the majority received 24-hour Holter monitors. All patients underwent extensive genetic testing and those found to have inherited channelopathies were excluded. All other patients who experienced unexplained cardiac arrest, resuscitated ventricular tachycardia, or ventricular fibrillation were included. A blinded reviewer reviewed all echocardiograms and strictly defined the presence of single or bileaflet MVP as systolic displacement of the mitral valve > 2 mm into the left atrium in the parasternal long axis view, along with thickened or myxomatous mitral valve leaflets.

    The authors identified 24 patients with unexplained cardiac arrest, normal QT intervals, and negative genetic testing (median age 33.5 years, 67% women). Bileaflet MVP was identified in 10 of 24 patients (42%, 9 females) with mitral regurgitation graded as mild in five, moderate in four, and severe in one patient. Biphasic or inverted T waves in the inferior leads were more commonly found in bileaflet MVP patients. Holter monitors were available in 9 of 10 SCA patients, and had significantly higher burden of premature ventricular contractions ([PVCs] 67 vs 23 PVCs/hr, P = 0.002), nonsustained ventricular tachycardia (7/9 patients), and ventricular bigemeny (9/9 patients) compared to those without MVP. A pattern of PVCs with alternating axis originating from the left ventricular outflow tract and papillary muscle/fascicular system was noted in seven of nine MVP patients who experienced SCA. Three patients underwent invasive electrophysiologic study and were found to have multiple PVC foci, typically originating near the left ventricular papillary muscles. After a mean of 1.8 years additional follow-up after the incident SCA, the only predictor of recurrent ventricular arrhythmias requiring defibrillator therapy was the presence of bileaflet MVP (odds ratio, 7.2; 95% confidence interval 1.1 to 48; P = 0.028). The authors concluded that there is a small subset of MVP patients characterized by bileaflet prolapse, female sex, and frequent complex ventricular ectopy who can have life-threatening ventricular tachyarrhythmias.

    Commentary

    The prevalence of MVP in the general population using strict echocardiographic criteria is 2-3%; however, some reports have more loosely described MVP in up to 30% of asymptomatic patients. The association of MVP with sudden death in autopsy studies often creates concern among patients informed they have MVP. However, a true association with MVP and sudden death has remained controversial. The current small series is interesting because all the patients who experienced SCA had echocardiograms and electrocardiograms available for review. The presence of bileaflet MVP in 42% of the cohort with unexplained SCA is certainly notable. However, several important qualifiers apply. The authors studied the incidence of SCA in a highly selected and specific population of SCA survivors. Thus, analogous to the early repolarization syndrome, which was recently described in a disproportionate number of survivors of cardiac arrest,1 the overall risk in the general population with MVP remains small. However, cardiologists are often asked to evaluate patients with recurrent syncope or cardiac arrest, or family members of SCA patients. This study highlights some important characteristics of a high-risk cohort that are worth noting. First, all of the described patients had "bileaflet" prolapse, which may be more specific than the single leaflet prolapse often described. These patients also had repolarization abnormalities (biphasic or inverted T waves) in the inferior leads, and Holter monitors showing complex ventricular ectopy, typically ventricular bigemeny in an alternating pattern of inferior and superior axis. Although the mechanism of these PVCs is unclear, it is certainly plausible to speculate that these originate from structural abnormalities in the mitral valve apparatus. Also noteworthy is the finding that the majority of patients experiencing SCA were young women and many of the patients had only mild or moderate mitral regurgitation.

    Therefore, before giving a patient the diagnosis of MVP, strict echocardiographic criteria should be applied. The majority of patients with asymptomatic single leaflet MVP have a benign prognosis. However, this report brings to light a potential higher risk cohort of patients with bileaflet MVP, repolarization abnormalities in the inferior ECG leads, and complex ventricular ectopy. While implantation of an implantable defibrillator in such patients is certainly premature, close follow-up or referral of high-risk patients for further evaluation is certainly warranted. Prospective studies of such patients will be difficult given the small population with these characteristics, but would certainly be useful for determining the optimal management strategy for these patients.

    REFERENCE

    1. Haïssaguerre M, et al. Sudden cardiac arrest associated with early repolarization. N Engl J Med 2008;358:2016-2023.

    Post a comment to this article

    Report Abusive Comment

    www.reliasmedia.com

    Clinical Cardiology Alert

    View PDF
    Clinical Cardiology Alert 2013-09-01
    September 1, 2013

    Table Of Contents

    BNP-Guided Heart Failure Prevention

    Who Should Get an ICD?

    Is Bileaflet Mitral Valve Prolapse Associated with Sudden Death?

    Same-Day Discharge After PCI

    Long-Term Results of Dabigatran vs Warfarin for Stroke Prevention in AF Patients

    Clinical Briefs in Primary Care

    Pharmacology Watch: Do Statins Prevent Parkinson’s Disease?

    Begin Test
    Buy this Issue/Course

    Shop Now: Search Products

    • Subscription Publications
    • Books & Study Guides
    • Webinars
    • Group & Site
      Licenses
    • State CME/CE
      Requirements

    Webinars And Events

    View All Events

    Free Email Newsletters

    All Fields Required

    E-Newsletter Options
    • Accreditation Council for Continuing Medical Education
    • American Nurses Credentialing Center
    • American College of Emergency Physician
    • American Board of Internal Medicine: Maintenance of Certification
    • California Board of Registered Nursing
    • Commission for Case Manager Certification
    • American Academy of Pediatrics
    • American Osteopathic Association
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Live Webinars
      • On-Demand Webinars
      • Libraries
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Live Webinars
      • On-Demand Webinars
      • Libraries
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Live Webinars
      • On-Demand Webinars
    • All Access
      • Learn More
      • My Subscription
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    • Help
    • Search
    • About Us
    • Sign In
    • Register
    Relias Media - Continuing Medical Education Publishing

    The trusted source for

    healthcare information and

    CONTINUING EDUCATION.

    Customer Service

    customerservice@reliasmedia.com

    U.S. and Canada: 1-800-688-2421

    International +1-404-262-5476

    Accounts Receivable

    1-800-370-9210
    ReliasMedia_AR@reliasmedia.com

    Mailing Address

    • 1010 Sync St., Suite 100
      Morrisville, NC 27560-5468
      USA

    © 2019 Relias. All rights reserved.

    Privacy Policy  Terms of Use  Contact Us  Reprints  Group Sales

    For DSR inquiries or complaints, please reach out to Wes Vaux, Data Privacy Officer, DPO@relias.com

    Design, CMS, Hosting & Web Development :: ePublishing